2-t-butoxypyrimidine | 107976-32-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2-t-butoxypyrimidine
• 英文别名: 2-(tert-butoxy)pyrimidine；t-Butoxypyrimidine；2-[(2-methylpropan-2-yl)oxy]pyrimidine
• CAS: 107976-32-9
• 化学式: C₈H₁₂N₂O
• 分子量: 152.196
• InChiKey: KTOZZUYPIQETBE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  35
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-t-butoxypyrimidine 生成 2-羟基嘧啶 、 乙烯
  参考文献：
  名称：

  Al-Awardi, Nouria; Taylor, Roger, Journal of the Chemical Society. Perkin transactions II, 1986, p. 1585 - 1588

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氯嘧啶 、 叔丁醇 在 氢化钾 作用下， 反应 2.0h， 以70%的产率得到2-t-butoxypyrimidine
  参考文献：
  名称：

  Al-Awardi, Nouria; Taylor, Roger, Journal of the Chemical Society. Perkin transactions II, 1986, p. 1585 - 1588

  摘要：

  DOI：

文献信息

• Decyanative Cross-Coupling of Cyanopyrimidines with O-, S-, and N-Nucleophiles: A Route to Alkoxylpyrimidines, Aminopyrimidines and Alkylthiopyrimidines
  作者：Xiangyang Wei、Caiyang Zhang、Yifei Wang、Qi Zhan、Guiying Qiu、Ling Fan、Guodong Yin

  DOI：10.1002/ejoc.201901364

  日期：2019.11.14

  A cross‐coupling reaction of cyanopyrimidines with aliphatic alcohols, thiols (or S‐alkylisothiourea salts) or amines gives the corresponding alkoxylpyrimidines, aminopyrimidines or alkylthiopyrimidines. The wide substrate scope with excellent yields makes cyanopyrimidines a promising alternative substrate class to the frequently used pyrimidines halides for the formation of C–O, C–S, and C–N bonds

  氰基嘧啶与脂族醇，硫醇（或S-烷基异硫脲盐）或胺的交叉偶联反应可得到相应的烷氧基嘧啶，氨基嘧啶或烷基硫嘧啶。宽范围的底物范围和优异的收率使氰基嘧啶成为用于形成C–O，C–S和C–N键的常用嘧啶卤化物的有前途的替代底物类别。
• Substituted Piperidines that Increase P53 Activity and the Uses Thereof
  申请人：Ma Yao

  公开号：US20080004287A1

  公开（公告）日：2008-01-03

  In its many embodiments, the present invention discloses novel compounds, as inhibitors of HDM2 protein, methods for preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of treatment, prevention, inhibition, of one or more diseases associated with the HDM2 protein or P53 using such compounds or pharmaceutical compositions.

  在其多种实施形式中，本发明披露了作为HDM2蛋白抑制剂的新型化合物，制备这种化合物的方法，包括一种或多种这种化合物的药物组合物，以及利用这种化合物或药物组合物进行与HDM2蛋白或P53相关的一种或多种疾病的治疗、预防、抑制方法。
• Novel Coumarin Derivative Having Antitumor Activity
  申请人：Iikura Hitoshi

  公开号：US20110092700A1

  公开（公告）日：2011-04-21

  The present invention provides a compound represented by general formula (1) below or a pharmaceutically acceptable salt thereof: wherein: X is selected from heteroaryl etc., Y 1 and Y 2 are selected from —N═ etc., Y 3 and Y 4 are selected from —CH═ etc., A is selected from sulfamide etc., R 1 is selected from hydrogen etc., and R 2 is selected from C 1-6 alkyl etc. The compound or salt has sufficiently high antitumor activity, and is useful in the treatment of cell proliferative disorders, particularly cancers. The present invention also provides a pharmaceutical composition containing the compound or salt as an active ingredient.

  本发明提供一种由下式（1）或其药学上可接受的盐所表示的化合物：其中，X选自杂环芳基等；Y1和Y2选自—N═等；Y3和Y4选自—CH═等；A选自磺酰胺等；R1选自氢等；R2选自C1-6烷基等。该化合物或盐具有足够高的抗肿瘤活性，并可用于治疗细胞增殖性疾病，特别是癌症。本发明还提供一种含有该化合物或盐作为活性成分的制药组合物。
• p27 Protein Inducer
  申请人：Sakai Toshiyuki

  公开号：US20110009398A1

  公开（公告）日：2011-01-13

  The present invention provides a p27 protein inducing agent comprising a compound represented by general formula (11) below or pharmaceutically acceptable salt thereof as an active ingredient: wherein G 1 , G 2 , G 3 and G 8 are each independently selected from —N═ etc., Ring G 6 is selected from divalent aryl etc., A is selected from amino etc., G 4 is selected from oxygen etc., G 5 is selected from oxygen etc., G 7 is selected from —CH 2 — etc., and R 2 is selected from C 1-6 alkyl etc.

  本发明提供了一种p27蛋白诱导剂，其包含以下通式（11）所表示的化合物或其药学上可接受的盐作为活性成分：其中G1，G2，G3和G8各自独立地选择自—N═等，环G6选择自双价芳基等，A选择自氨基等，G4选择自氧等，G5选择自氧等，G7选择自—CH2—等，R2选择自C1-6烷基等。
• Tricyclic Gyrase inhibitors
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US10865216B2

  公开（公告）日：2020-12-15

  Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors. In addition, species of tricyclic gyrase inhibitors compounds are also disclosed herein. Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.

  本文公开了具有式 I 结构的化合物及其药学上适用的盐、酯和原药，它们可作为抗菌有效的三环回旋酶抑制剂。此外，本文还公开了三环回旋酶抑制剂化合物的种类。 还考虑了相关的药物组合物、用途和化合物的制造方法。